BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34593869)

  • 1. Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response.
    Evangelopoulos ME; Nasiri-Ansari N; Kassi E; Papadopoulou A; Evangelopoulos DS; Moutsatsou P
    Sci Rep; 2021 Sep; 11(1):19462. PubMed ID: 34593869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.
    De Andres C; García MI; Goicoechea H; Martínez-Ginés ML; García-Domínguez JM; Martín ML; Romero-Delgado F; Benguría A; Sanjurjo M; López-Fernández LA
    Pharmacogenomics J; 2018 Jan; 18(1):98-105. PubMed ID: 27670768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
    Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse.
    Hecker M; Fitzner B; Koczan D; Klehmet J; Grothe M; Schwab M; Winkelmann A; Meister S; Dudesek A; Ludwig-Portugall I; Eulitz K; Zettl UK
    Biomed Pharmacother; 2024 Jun; 175():116721. PubMed ID: 38749180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-examining the effects of high-dose intravenous methylprednisolone for secondary progressive multiple sclerosis.
    Jalipa FGU; Espiritu AI; Pasco PMD
    Neurodegener Dis Manag; 2021 Apr; 11(2):177-185. PubMed ID: 33703936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
    Nos C; Sastre-Garriga J; Borràs C; Río J; Tintoré M; Montalban X
    Mult Scler; 2004 Aug; 10(4):413-6. PubMed ID: 15327039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
    Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
    Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
    Cohen JA; Imrey PB; Calabresi PA; Edwards KR; Eickenhorst T; Felton WL; Fisher E; Fox RJ; Goodman AD; Hara-Cleaver C; Hutton GJ; Mandell BF; Scott TF; Zhang H; Apperson-Hansen C; Beck GJ; Houghtaling PL; Karafa MT; Stadtler M;
    Neurology; 2009 Feb; 72(6):535-41. PubMed ID: 19204263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
    Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C
    Mult Scler; 2015 Apr; 21(5):646-50. PubMed ID: 25145693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.
    Morrow SA; Stoian CA; Dmitrovic J; Chan SC; Metz LM
    Neurology; 2004 Sep; 63(6):1079-80. PubMed ID: 15452302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
    Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
    Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses.
    Filipović Grčić P; Matijaca M; Lušić I; Čapkun V
    Med Sci Monit; 2011 Dec; 17(12):CR704-10. PubMed ID: 22129902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses.
    Chapman C; Tubridy N; Cook MJ; Mitchell PJ; MacGregor LR; Lovelock C; Litewka L; Sedal L; Kilpatrick TJ; Butzkueven H
    J Clin Neurosci; 2006 Jul; 13(6):636-8. PubMed ID: 16790352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis.
    Ozkan S; Uzuner N; Kutlu C; Ozbabalik D; Ozdemir G
    J Clin Neurosci; 2006 Feb; 13(2):214-7. PubMed ID: 16503485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.
    Rao AB; Richert N; Howard T; Lewis BK; Bash CN; McFarland HF; Frank JA
    Neurology; 2002 Sep; 59(5):688-94. PubMed ID: 12221158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
    Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
    Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.